Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

16.4K
Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
16.4K
General Transcription Factors01:30

General Transcription Factors

6.0K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
6.0K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

427
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
427
Coordination of Gene Expression Processes in Bacteria01:29

Coordination of Gene Expression Processes in Bacteria

266
The DNA replication, transcription, and translation processes are intricately coupled in bacteria, allowing efficient gene expression and rapid protein synthesis. While this physical and functional coordination is advantageous, it introduces challenges that bacteria overcome through specific regulatory mechanisms.Coupling of Replication, Transcription, and TranslationThe coupling of replication, transcription, and translation is a hallmark of bacterial gene expression. As the replisome unwinds...
266
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

281
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
281
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

706
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
706

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Erratum for Theriault et al., "Utilization of a CRISPRi-based <i>ex vivo</i> challenge model to reveal temporally dependent gene essentiality in intracellular <i>Mycobacterium tuberculosis</i>".

mBio·2026
Same author

Identification and Evaluation of Dibasic Piperidines as Cell Wall Inhibitors against <i>Mycobacterium tuberculosis</i>.

ACS infectious diseases·2026
Same author

Interstitial and recruited macrophages prevent tuberculosis relapse by limiting immune evasion.

EMBO molecular medicine·2026
Same author

Design, Synthesis and Biological Evaluation of Potent Piperazine-Based BioA Inhibitors Targeting Biotin Biosynthesis in <i>Mycobacterium tuberculosis</i>.

Journal of medicinal chemistry·2026
Same author

Utilization of a CRISPRi-based <i>ex vivo</i> challenge model to reveal temporally dependent gene essentiality in intracellular <i>Mycobacterium tuberculosis</i>.

mBio·2026
Same author

Mycobacterium tuberculosis long-chain fatty acid resistome reveals universal stress protein TB15.3 as essential for infection.

Communications biology·2026

Video Experimental Relacionado

Updated: Oct 27, 2025

A Novel Microdissection Approach to Recovering Mycobacterium tuberculosis Specific Transcripts from Formalin Fixed Paraffin Embedded Lung Granulomas
07:42

A Novel Microdissection Approach to Recovering Mycobacterium tuberculosis Specific Transcripts from Formalin Fixed Paraffin Embedded Lung Granulomas

Published on: June 5, 2014

8.2K

El ajuste de la expresión génica en todo el genoma revela diversas vulnerabilidades de M. tuberculosis

Barbara Bosch1, Michael A DeJesus1, Nicholas C Poulton1

  • 1Laboratory of Host-Pathogen Biology, The Rockefeller University, New York, NY 10065, USA.

Cell
|July 23, 2021
PubMed
Resumen

Este estudio introduce la vulnerabilidad genética, una nueva métrica para los objetivos farmacológicos bacterianos. Redefine los genes esenciales al cuantificar los costos de la aptitud por inhibición parcial, ayudando al descubrimiento de nuevos objetivos antibacterianos.

Palabras clave:
Teorema de BayesSistemas CRISPR-CasDesarrollo de drogasLos genes esencialesEspectrometría de masasLas bacterias Mycobacterium smegmatisLa tuberculosis por micobacteriasVulnerabilidad

Más Videos Relacionados

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.9K
Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems
06:18

Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems

Published on: April 26, 2019

6.1K

Videos de Experimentos Relacionados

Last Updated: Oct 27, 2025

A Novel Microdissection Approach to Recovering Mycobacterium tuberculosis Specific Transcripts from Formalin Fixed Paraffin Embedded Lung Granulomas
07:42

A Novel Microdissection Approach to Recovering Mycobacterium tuberculosis Specific Transcripts from Formalin Fixed Paraffin Embedded Lung Granulomas

Published on: June 5, 2014

8.2K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.9K
Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems
06:18

Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems

Published on: April 26, 2019

6.1K

Área de la Ciencia:

  • Bacteriología y Genética Microbiana
  • Genómica funcional y descubrimiento de fármacos

Sus antecedentes:

  • Los métodos tradicionales definen los genes esenciales como todo o nada, sin identificar objetivos donde la inhibición parcial causa costos de aptitud significativos.
  • Los agentes antibacterianos existentes a menudo logran una inhibición incompleta del objetivo, lo que limita la eficacia y requiere nuevas estrategias de identificación del objetivo.

Objetivo del estudio:

  • Desarrollar y aplicar un método de genómica funcional para evaluar sistemáticamente la vulnerabilidad genética de Mycobacterium tuberculosis (Mtb).
  • Identificar nuevos objetivos de fármacos antibacterianos de alto valor basados en la vulnerabilidad genética cuantitativa.
  • Comparar la vulnerabilidad genética entre diferentes cepas de Mtb y correlacionarla con la susceptibilidad antibacteriana.

Principales métodos:

  • Desarrolló un sistema basado en la interferencia CRISPR (CRISPRi) para la titulación de la expresión génica en Mtb.
  • Resultados de aptitud bacteriana cuantificados en respuesta a diferentes niveles de inhibición génica.
  • Se realizaron análisis comparativos de la vulnerabilidad genética entre los aislados de Mtb de referencia y los hipervirulentos.

Principales resultados:

  • Identificó numerosos genes esenciales altamente vulnerables en varios procesos celulares, incluidos nuevos objetivos para el descubrimiento de fármacos.
  • Descubrieron genes esenciales invulnerables, lo que podría explicar los fracasos del pasado en el descubrimiento de medicamentos.
  • Se demostró que la vulnerabilidad genética no se conserva completamente en las cepas Mtb y puede predecir la susceptibilidad antibacteriana diferencial.

Conclusiones:

  • La vulnerabilidad genética proporciona una medida cuantitativa para redefinir los procesos bacterianos esenciales e identificar objetivos farmacológicos superiores.
  • Este enfoque mejora el descubrimiento de nuevos agentes antibacterianos al enfocarse en genes cuya inhibición parcial impacta gravemente en la aptitud bacteriana.
  • La vulnerabilidad genética diferencial entre las cepas de Mtb ofrece información sobre las respuestas a los medicamentos específicas de la cepa y los mecanismos potenciales de resistencia.